scholarly journals Blood or Viral Antigen Purification

2020 ◽  
Author(s):  
Keyword(s):  
Viral Antigen ◽  
Antigen Purification

Antibody Therapy for the Control of Viral Diseases: An Update

2019 ◽  
Vol 20 (13) ◽  
pp. 1108-1121 ◽  
Author(s):  
Miriam Dibo ◽  
Eduardo C. Battocchio ◽  
Lucas M. dos Santos Souza ◽  
Matheus D. Veloso da Silva ◽  
Bruna K. Banin-Hirata ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Monoclonal Antibodies ◽  
Viral Antigen ◽  
Viral Infections ◽  
Antibody Therapy ◽  
Therapeutic Strategies ◽  
Viral Diseases ◽  
Specific Antibodies ◽  
The Status ◽  
Epidemiological Impact

The epidemiological impact of viral diseases, combined with the emergence and reemergence of some viruses, and the difficulties in identifying effective therapies, have encouraged several studies to develop new therapeutic strategies for viral infections. In this context, the use of immunotherapy for the treatment of viral diseases is increasing. One of the strategies of immunotherapy is the use of antibodies, particularly the monoclonal antibodies (mAbs) and multi-specific antibodies, which bind directly to the viral antigen and bring about activation of the immune system. With current advancements in science and technology, several such antibodies are being tested, and some are already approved and are undergoing clinical trials. The present work aims to review the status of mAb development for the treatment of viral diseases.

Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43

1999 ◽  
Vol 73 (4) ◽  
pp. 3338-3350 ◽  
Author(s):  
Nathalie Arbour ◽  
Geneviève Côté ◽  
Claude Lachance ◽  
Marc Tardieu ◽  
Neil R. Cashman ◽  
...  
Keyword(s):  
Nervous System ◽  
Cell Lines ◽  
Persistent Infection ◽  
Viral Antigen ◽  
Primary Cultures ◽  
Point Mutations ◽  
Neural Cell ◽  
Persistently Infected ◽  
Human Neural Cell ◽  
Neural Cell Lines

ABSTRACT Human coronaviruses (HuCV) are recognized respiratory pathogens. Data accumulated by different laboratories suggest their neurotropic potential. For example, primary cultures of human astrocytes and microglia were shown to be susceptible to an infection by the OC43 strain of HuCV (A. Bonavia, N. Arbour, V. W. Yong, and P. J. Talbot, J. Virol. 71:800–806, 1997). We speculate that the neurotropism of HuCV will lead to persistence within the central nervous system, as was observed for murine coronaviruses. As a first step in the verification of our hypothesis, we have characterized the susceptibility of various human neural cell lines to infection by HuCV-OC43. Viral antigen, infectious virus progeny, and viral RNA were monitored during both acute and persistent infections. The astrocytoma cell lines U-87 MG, U-373 MG, and GL-15, as well as neuroblastoma SK-N-SH, neuroglioma H4, oligodendrocytic MO3.13, and the CHME-5 immortalized fetal microglial cell lines, were all susceptible to an acute infection by HuCV-OC43. Viral antigen and RNA and release of infectious virions were observed during persistent HuCV-OC43 infections (∼130 days of culture) of U-87 MG, U-373 MG, MO3.13, and H4 cell lines. Nucleotide sequences of RNA encoding the putatively hypervariable viral S1 gene fragment obtained after 130 days of culture were compared to that of initial virus input. Point mutations leading to amino acid changes were observed in all persistently infected cell lines. Moreover, an in-frame deletion was also observed in persistently infected H4 cells. Some point mutations were observed in some molecular clones but not all, suggesting evolution of the viral population and the emergence of viral quasispecies during persistent infection of H4, U-87 MG, and MO3.13 cell lines. These results are consistent with the potential persistence of HuCV-OC43 in cells of the human nervous system, accompanied by the production of infectious virions and molecular variation of viral genomic RNA.

scholarly journals Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells

Viruses ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 753
Author(s):  
Mohammad Haque ◽  
Fengyang Lei ◽  
Xiaofang Xiong ◽  
Yijie Ren ◽  
Hao-Yun Peng ◽  
...  
Keyword(s):  
T Cells ◽  
Stem Cell ◽  
Adoptive Transfer ◽  
Cd4 T Cells ◽  
Viral Antigen ◽  
Peritoneal Macrophages ◽  
Hiv Replication ◽  
Specific Ctls ◽  
Immunodeficiency Virus ◽  
Hiv 1

The viral antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) derived from pluripotent stem cells (PSCs), i.e., PSC-CTLs, have the ability to suppress the human immunodeficiency virus (HIV) infection. After adoptive transfer, PSC-CTLs can infiltrate into the local tissues to suppress HIV replication. Nevertheless, the mechanisms by which the viral Ag-specific PSC-CTLs elicit the antiviral response remain to be fully elucidated. In this study, we generated the functional HIV-1 Gag epitope SL9-specific CTLs from the induced PSC (iPSCs), i.e., iPSC-CTLs, and investigated the suppression of SL9-specific iPSC-CTLs on viral replication and the protection of CD4+ T cells. A chimeric HIV-1, i.e., EcoHIV, was used to produce HIV replication in mice. We show that adoptive transfer of SL9-specific iPSC-CTLs greatly suppressed EcoHIV replication in the peritoneal macrophages and spleen in the animal model. Furthermore, we demonstrate that the adoptive transfer significantly reduced expression of PD-1 on CD4+ T cells in the spleen and generated persistent anti-HIV memory T cells. These results indicate that stem cell-derived viral Ag-specific CTLs can robustly accumulate in the local tissues to suppress HIV replication and prevent CD4+ T cell exhaustion through reduction of PD-1 expression.

Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes

1998 ◽  
Vol 28 (9) ◽  
pp. 2791-2800 ◽  
Author(s):  
Ian H. Frazer ◽  
Germain J. P. Fernando ◽  
Nina Fowler ◽  
Graham R. Leggatt ◽  
Paul F. Lambert ◽  
...  
Keyword(s):  
Viral Antigen ◽  
Thymic Epithelium ◽  
Split Tolerance

Analyse des Vermehrungsmechanismus des Newcastle disease Virus (NDV) mit Hilfe verschiedener Inhibitoren

1967 ◽  
Vol 22 (12) ◽  
pp. 1319-1330 ◽  
Author(s):  
Werner Schäfer ◽  
Liselotte Pister ◽  
Rita Schneider
Keyword(s):  
Chick Embryo ◽  
Viral Antigen ◽  
Rna Synthesis ◽  
Protein S ◽  
Viral Rna ◽  
Chick Embryo Fibroblast ◽  
Sensitive Material ◽  
Sensitive Phase ◽  
Antigenic Material ◽  
Structural Antigen

The reproduction of NDV in chick-embryo-fibroblast cultures was studied with 6-Azauridine, 8-Azaguanine, Parafluorophenylalanine (FPA) and Puromycine as inhibitors. The results suggest that no virus initiated FPA-sensitive material is needed for the uncoating of the infecting particles, and that viral parental RNA is able to induce the formation of protein (s) needed for viral RNA-synthesis (“RNA-protein“) as well as the production of viral structural antigen (s). Further antigenic material appears after the beginning of new viral RNA-synthesis. The “RNA-protein (s)“become (s) detectable between 2 and 3 hours after infection and is (are) stable in its function over several hours. According to the formation of viral antigenic material parental viral RNA can act as a messenger longer than 9 hours. The capacity for the production of hemagglutinating units appears after the viral antigen producing capacity, when viral RNA can already be synthesized. This capacity is separated from that to produce plaque forming particles by a FPA-sensitive phase. The character of the corresponding FPA-sensititve material is unknown.

scholarly journals Detection of avian encephalomyelitis viral antigen with a monoclonal antibody

1994 ◽  
Vol 23 (1) ◽  
pp. 49-59
Author(s):  
K. Ohishi ◽  
M. Senda ◽  
H. Yamamoto ◽  
H. Nagai ◽  
M. Norimatsu ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Viral Antigen

scholarly journals Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells

Blood ◽  
2012 ◽  
Vol 120 (16) ◽  
pp. 3237-3245 ◽  
Author(s):  
Corey Smith ◽  
Diah Elhassen ◽  
Stephanie Gras ◽  
Katherine K. Wynn ◽  
Vijayendra Dasari ◽  
...  
Keyword(s):  
T Cells ◽  
Transcription Factors ◽  
Antigen Presentation ◽  
Cd8 T Cells ◽  
Viral Antigen ◽  
Cytotoxic T Lymphocyte ◽  
Granzyme B ◽  
T Box ◽  
Differentiation Status ◽  
Human Cmv

Abstract T-box transcription factors T-bet (Tbx21) and Eomesodermin (Eomes) are critical players in CD8+ cytotoxic T lymphocyte effector function and differentiation, but how the expression of these transcription factors is regulated remains poorly defined. Here we show that dominant T cells directed toward human CMV, expressing significantly higher levels of T-bet with graded loss of Eomes expression (T-bethiEomeshi/lo), are more efficient in recognizing endogenously processed peptide-major histocompatibility complexes (pMHC) compared with subdominant virus-specific T cells expressing lower levels of T-bet and high levels of Eomes (T-betintEomeshi). Paradoxically, the T-bethiEomeshi/lo dominant populations that efficiently recognized endogenous antigen demonstrated lower intrinsic avidity for pMHC, whereas T-betintEomeshi subdominant populations were characterized by higher pMHC avidity and less efficient recognition of virus-infected cells. Importantly, differential endogenous viral antigen recognition by CMV-specific CD8+ T cells also correlated with the differentiation status and expression of perforin, granzyme B and K. Furthermore, we demonstrate that the expression of T-bet correlates with clonal expansion, differentiation status, and expression of perforin, granzyme B and K in antigen-specific T cells. These findings illustrate how endogenous viral antigen presentation during persistent viral infection may influence the transcriptional program of virus-specific T cells and their functional profile in the peripheral blood of humans.

Sign in / Sign up

Export Citation Format

Share Document